tosufloxacin has been researched along with Hematologic Malignancies in 2 studies
tosufloxacin: quinolone anti-infective agent; structure given in first source
tosufloxacin : A racemate comprising equimolar amounts of (R)- and (S)-tosufloxacin.
7-(3-aminopyrrolidin-1-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid : A 1,8-naphthyridine derivative that is 4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid bearing additional 2,4-difluorophenyl, fluoro and 3-aminopyrrolidin-1-yl substituents at positions 1, 6 and 7 respectively.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shinohara, A | 1 |
| Yoshiki, Y | 1 |
| Masamoto, Y | 1 |
| Hangaishi, A | 1 |
| Nannya, Y | 1 |
| Kurokawa, M | 1 |
| Haeusler, GM | 1 |
| Slavin, MA | 1 |
2 other studies available for tosufloxacin and Hematologic Malignancies
| Article | Year |
|---|---|
Moxifloxacin is more effective than tosufloxacin in reducing chemotherapy-induced febrile neutropenia in patients with hematological malignancies.
Topics: Adult; Aged; Antibiotic Prophylaxis; Antineoplastic Agents; Aza Compounds; Female; Fever; Fluoroquin | 2013 |
Fluoroquinolone prophylaxis: worth the cost?
Topics: Antineoplastic Agents; Aza Compounds; Female; Fever; Fluoroquinolones; Hematologic Neoplasms; Humans | 2013 |